PMC:7228307 / 42657-42875 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"725","span":{"begin":143,"end":158},"obj":"Chemical"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T360","span":{"begin":166,"end":176},"obj":"Body_part"}],"attributes":[{"id":"A360","pred":"fma_id","subj":"T360","obj":"http://purl.org/sig/ont/fma/fma82739"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T765","span":{"begin":108,"end":111},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T766","span":{"begin":205,"end":207},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T219","span":{"begin":166,"end":176},"obj":"Chemical"},{"id":"T220","span":{"begin":166,"end":171},"obj":"Chemical"},{"id":"T221","span":{"begin":172,"end":176},"obj":"Chemical"}],"attributes":[{"id":"A219","pred":"chebi_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/CHEBI_33709"},{"id":"A220","pred":"chebi_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/CHEBI_46882"},{"id":"A221","pred":"chebi_id","subj":"T221","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T46","span":{"begin":166,"end":176},"obj":"Chemical"}],"attributes":[{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_33709"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"725","span":{"begin":143,"end":158},"obj":"Chemical"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T240","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T241","span":{"begin":86,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T359","span":{"begin":166,"end":176},"obj":"Body_part"}],"attributes":[{"id":"A359","pred":"fma_id","subj":"T359","obj":"http://purl.org/sig/ont/fma/fma82739"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T240","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T241","span":{"begin":86,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"At the time of writing, some mAbs with improved potency are coming into clinical use. Their improved action has been achieved by modifying the N‐linked glycan or the amino acid sequence of the heavy‐chain Fc (Table 4)."}